Menart V - Search Results

1

New TNF-alpha analogues: a powerful but less toxic biological tool against tumours.

Novaković S, Menart V, Gaberc-Porekar V, Stalc A, Sersa G, Cemazar M, Jezersek B. Novaković S, et al. Among authors: menart v. Cytokine. 1997 Aug;9(8):597-604. doi: 10.1006/cyto.1997.0207. Cytokine. 1997. PMID: 9245488

2

Improvement of potential therapeutic value of tumor necrosis-alpha (TNF-alpha) by charge modulation in the tip region.

Fonda I, Pernus M, Gaberc-Porekar V, Kenig M, Stalc A, Meager A, Menart V. Fonda I, et al. Among authors: menart v. Eur Cytokine Netw. 2005 Jan-Mar;16(1):17-26. Eur Cytokine Netw. 2005. PMID: 15809202 Free article.

3

Searching for new TNF-alpha analogs having potential application in cancer therapy.

Menart V, Kus B, Novaković S, Sersa G, Gaberc-Porekar V, Harb V, Milicić S, Stalc A. Menart V, et al. Pflugers Arch. 1996;431(6 Suppl 2):R233-4. doi: 10.1007/BF02346354. Pflugers Arch. 1996. PMID: 8739350

4

Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice.

Sersa G, Cemazar M, Menart V, Gaberc-Porekar V, Miklavcic D. Sersa G, et al. Among authors: menart v. Cancer Lett. 1997 Jun 3;116(1):85-92. doi: 10.1016/s0304-3835(97)00170-5. Cancer Lett. 1997. PMID: 9177462

5

Attachment of histidine tags to recombinant tumor necrosis factor-alpha drastically changes its properties.

Fonda I, Kenig M, Gaberc-Porekar V, Pristovaek P, Menart V. Fonda I, et al. Among authors: menart v. ScientificWorldJournal. 2002 May 15;2:1312-25. doi: 10.1100/tsw.2002.215. ScientificWorldJournal. 2002. PMID: 12805914 Free PMC article.

6

Identification of the heparin-binding domain of TNF-alpha and its use for efficient TNF-alpha purification by heparin-Sepharose affinity chromatography.

Kenig M, Gaberc-Porekar V, Fonda I, Menart V. Kenig M, et al. Among authors: menart v. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 May 1;867(1):119-25. doi: 10.1016/j.jchromb.2008.03.023. Epub 2008 Apr 1. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18424242

7

Purification of human tumour necrosis factor by membrane chromatography.

Luksa J, Menart V, Milicic S, Kus B, Gaberc-Porekar V, Josic D. Luksa J, et al. Among authors: menart v. J Chromatogr A. 1994 Feb 11;661(1-2):161-8. doi: 10.1016/0021-9673(94)85186-7. J Chromatogr A. 1994. PMID: 8136904

8

Histidines in affinity tags and surface clusters for immobilized metal-ion affinity chromatography of trimeric tumor necrosis factor alpha.

Gaberc-Porekar V, Menart V, Jevsevar S, Vidensek A, Stalc A. Gaberc-Porekar V, et al. Among authors: menart v. J Chromatogr A. 1999 Aug 6;852(1):117-28. doi: 10.1016/s0021-9673(99)00374-x. J Chromatogr A. 1999. PMID: 10480237

9

Early events in TNFa-p55 receptor interations--experiments with TNF dimers.

Menart V, Gaberc-Porekar V, Jevsevar S, Pernus M, Meager A, Stalc A. Menart V, et al. Pflugers Arch. 2000;439(3 Suppl):R113-5. Pflugers Arch. 2000. PMID: 10653161

10

Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population.

Galvani V, Pretnar Hartman K, Rupreht RR, Novaković S, Stabuc B, Ocvirk J, Menart V, Gaberc Porekar V, Stalc A, Rozman P, Curin Serbec V. Galvani V, et al. Among authors: menart v. Pflugers Arch. 2000;440(5 Suppl):R61-3. Pflugers Arch. 2000. PMID: 11005614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters